INVITRO ACTIVITY OF THE NEW 4-QUINOLONE COMPOUND RO 23-6240

被引:17
作者
CLARKE, AM
ZEMCOV, SJV
机构
关键词
D O I
10.1007/BF02018199
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:161 / 164
页数:4
相关论文
共 5 条
[1]   INVITRO ACTIVITY OF ENOXACIN, A QUINOLONE CARBOXYLIC-ACID, COMPARED WITH THOSE OF NORFLOXACIN, NEW BETA-LACTAMS, AMINOGLYCOSIDES, AND TRIMETHOPRIM [J].
CHIN, NX ;
NEU, HC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 24 (05) :754-763
[2]   INVITRO ACTIVITY OF RO-23-6240, A NEW FLUORINATED 4-QUINOLONE [J].
CHIN, NX ;
BRITTAIN, DC ;
NEU, HC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 29 (04) :675-680
[3]   INVITRO ACTIVITY OF PEFLOXACIN COMPARED TO ENOXACIN, NORFLOXACIN, GENTAMICIN AND NEW BETA-LACTAMS [J].
CLARKE, AM ;
ZEMCOV, SJV ;
CAMPBELL, ME .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1985, 15 (01) :39-44
[4]   INVITRO ANTIBACTERIAL ACTIVITY OF NORFLOXACIN (MK-0366) [J].
KING, A ;
WARREN, C ;
SHANNON, K ;
PHILLIPS, I .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1982, 21 (04) :604-607
[5]   INVITRO ACTIVITY OF BAY-09867, A NEW QUINOLINE DERIVATIVE, COMPARED WITH THOSE OF OTHER ANTI-MICROBIAL AGENTS [J].
WISE, R ;
ANDREWS, JM ;
EDWARDS, LJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 23 (04) :559-564